Mechanism of Action

 

  • Univestin® has a unique mechanism of action modulating the COX and LOX enzymatic pathways by causing a balanced inhibition of COX-1 & COX-2 while simultaneously increasing antioxidant activity.

Key Pointers

 
  • Clinically tested for its efficacy and safety in 6 published clinical trials
  • Proven to be better than Naproxen and Celecoxib
  • Shows 7.79 % change in ROM (Range Of Motion)
  • Clinically shown to increase range of motion and physical function within 7 days
  • Clinically proven to provide rapid and long lasting relief from joint discomfort

Clinical Findings

 
  • In a clinical study on subjects with knee osteoarthritis, AmLexin™ at 400mg is clinically proven to reduce cartilage degradation significantly better than Glucosamine 1500mg and Chondroitin 1200mg
  • Proven significantly better at reducing uCTX-II, a type II collagen degradation biomarker by 8.9%
  • Proven to support exercise recovery and reduce delayed onset of muscular soreness (DOMS) in a second clinical trial, on subjects performing strenous sport activity
  • AmLexin™ has been shown to be effective in an ex vivo GAG assay, at reducing Glycosaminoglycan (GAG) released by articular cartilage

Indication

Joint Pain & Stiffness Osteoarthritis

Dosage Forms

  • Tablets

  • Capsules

  • Gummies

  • Sachets